NeuPath Health Inc (NPTH) — Cash Flow Reinvestment Rate
Latest as of December 2025:
0.37x
NeuPath Health Inc (NPTH) has a Cash Flow Reinvestment Rate of 0.37x as of December 2025, reinvesting CA$245.00K (capex CA$245.00K ) from operating cash flow of CA$662.00K. See NPTH free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.37x
(Capex + Investments) / Operating CF
Total Reinvested
CA$245.00K
Capex + Investments
Operating Cash Flow
CA$662.00K
CAD
Capital Expenditures
CA$245.00K
CAD
NeuPath Health Inc Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for NeuPath Health Inc across 5 annual periods. For the full cash flow conversion analysis, see NPTH cash flow conversion.
Annual Cash Flow Reinvestment Rate for NeuPath Health Inc (2021–2025)
Year-by-year capital reinvestment analysis for NeuPath Health Inc. See financial agility of NeuPath Health Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | CA$863.00K | CA$4.00 Million | CA$863.00K | ▼ -72.7% |
| 2024 | 0.79x | CA$2.06 Million | CA$2.61 Million | CA$948.00K | ▲ +22.9% |
| 2023 | 0.64x | CA$1.94 Million | CA$3.03 Million | CA$353.00K | ▼ -83.7% |
| 2022 | 3.93x | CA$2.90 Million | CA$738.00K | CA$1.23 Million | ▲ +93.1% |
| 2021 | 2.04x | CA$3.91 Million | CA$1.92 Million | CA$411.00K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow